Tuesday, February 7, 2012

Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment for the Contrave® Outcomes Trial - PR Newswire - sacbee.com

Orexigen® Announces Agreement From the FDA on a Special Protocol Assessment for the Contrave® Outcomes Trial - PR Newswire - sacbee.com

No comments:

Post a Comment